{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:30:42Z","timestamp":1785439842420,"version":"3.56.0"},"reference-count":39,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.5551\/jat.61630","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T22:08:59Z","timestamp":1619820539000},"page":"775-784","source":"Crossref","is-referenced-by-count":5,"title":["Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation"],"prefix":"10.5551","volume":"29","author":[{"given":"Tomohiro","family":"Komatsu","sequence":"first","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ayaori","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"},{"name":"Tokorozawa Heart Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Uto-Kondo","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Tokorozawa PET Imaging Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nishida","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Takiguchi","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yakushiji","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nakaya","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Ikewaki","sequence":"additional","affiliation":[{"name":"Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Libby P and Hansson GK: Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res, 2015; 116: 307-311","DOI":"10.1161\/CIRCRESAHA.116.301313"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Verma S, Szmitko PE and Ridker PM: C-reactive protein comes of age. Nat Clin Pract Cardiovasc Med, 2005; 2: 29-36; quiz 58","DOI":"10.1038\/ncpcardio0074"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Koenig W: High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol, 2013; 168: 5126-5134","DOI":"10.1016\/j.ijcard.2013.07.113"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr., Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT and Glynn RJ: Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet, 2009; 373: 1175-1182","DOI":"10.1016\/S0140-6736(09)60447-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Teupser D, Weber O, Rao TN, Sass K, Thiery J and Fehling HJ: No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice. J Biol Chem, 2011; 286: 6272-6279","DOI":"10.1074\/jbc.M110.161414"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hirschfield GM, Gallimore JR, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA and Pepys MB: Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A, 2005; 102: 8309-8314","DOI":"10.1073\/pnas.0503202102"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Reifenberg K, Lehr HA, Baskal D, Wiese E, Schaefer SC, Black S, Samols D, Torzewski M, Lackner KJ, Husmann M, Blettner M and Bhakdi S: Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol, 2005; 25: 1641-1646","DOI":"10.1161\/01.ATV.0000171983.95612.90"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Oesterle A and Bowman MA: S100A12 and the S100\/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets. Arterioscler Thromb Vasc Biol, 2015; 35: 2496-2507","DOI":"10.1161\/ATVBAHA.115.302072"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hofmann Bowman MA, Gawdzik J, Bukhari U, Husain AN, Toth PT, Kim G, Earley J and McNally EM: S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler Thromb Vasc Biol, 2011; 31: 337-344","DOI":"10.1161\/ATVBAHA.110.217745"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yan L, Bjork P, Butuc R, Gawdzik J, Earley J, Kim G and Hofmann Bowman MA: Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. Atherosclerosis, 2013; 228: 69-79","DOI":"10.1016\/j.atherosclerosis.2013.02.023"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Saito T, Hojo Y, Ogoyama Y, Hirose M, Ikemoto T, Katsuki T, Shimada K and Kario K: S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease. Circ J, 2012; 76: 2647-2652","DOI":"10.1253\/circj.CJ-12-0093"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Grauen Larsen H, Yndigegn T, Marinkovic G, Grufman H, Mares R, Nilsson J, Goncalves I and Schiopu A: The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event. Atherosclerosis, 2019; 287: 16-23","DOI":"10.1016\/j.atherosclerosis.2019.05.020"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Liu J, Ren YG, Zhang LH, Tong YW and Kang L: Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease. Scand J Clin Lab Invest, 2014; 74: 149-154","DOI":"10.3109\/00365513.2013.864786"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Abbas A, Aukrust P, Dahl TB, Bjerkeli V, Sagen EB, Michelsen A, Russell D, Krohg-Sorensen K, Holm S, Skjelland M and Halvorsen B: High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis. Stroke, 2012; 43: 1347-1353","DOI":"10.1161\/STROKEAHA.111.642256"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Whitehead AL, Julious SA, Cooper CL and Campbell MJ: Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res, 2016; 25: 1057-1073","DOI":"10.1177\/0962280215588241"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M and Yokote K: Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb, 2013; 20: 835-849","DOI":"10.5551\/jat.18820"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kotani K, Maekawa M, Kanno T, Kondo A, Toda N and Manabe M: Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta, 1994; 1215: 121-125","DOI":"10.1016\/0005-2760(94)90100-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N and Imaizumi T: Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol, 2006; 48: 1825-1831","DOI":"10.1016\/j.jacc.2006.03.069"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J and Vogel R: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 2002; 39: 257-265","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Takiguchi S, Ayaori M, Uto-Kondo H, Iizuka M, Sasaki M, Komatsu T, Takase B, Adachi T, Ohsuzu F and Ikewaki K: Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase. Hypertens Res, 2011; 34: 686-692","DOI":"10.1038\/hr.2011.11"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T and Araki E: Japanese Clinical Practice Guideline for Diabetes 2016. Diabetol Int, 2018; 9: 1-45","DOI":"10.1007\/s13340-018-0345-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Arevalo-Lorido JC: Clinical relevance for lowering C-reactive protein with statins. Ann Med, 2016; 48: 516-524","DOI":"10.1080\/07853890.2016.1197413"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ridker PM: From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res, 2016; 118: 145-156","DOI":"10.1161\/CIRCRESAHA.115.306656"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Averill MM, Kerkhoff C and Bornfeldt KE: S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol, 2012; 32: 223-229","DOI":"10.1161\/ATVBAHA.111.236927"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D and Schmidt AM: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell, 1999; 97: 889-901","DOI":"10.1016\/S0092-8674(00)80801-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Zackular JP, Chazin WJ and Skaar EP: Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface. J Biol Chem, 2015; 290: 18991-18998","DOI":"10.1074\/jbc.R115.645085"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Wittkowski H, Foell D, af Klint E, De Rycke L, De Keyser F, Frosch M, Ulfgren AK and Roth J: Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann Rheum Dis, 2007; 66: 1020-1025","DOI":"10.1136\/ard.2006.061507"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nordal HH, Brun JG, Halse AK, Jonsson R, Fagerhol MK and Hammer HB: The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab. BMC Musculoskelet Disord, 2014; 15: 335","DOI":"10.1186\/1471-2474-15-335"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Brinar M, Cleynen I, Coopmans T, Van Assche G, Rutgeerts P and Vermeire S: Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity. Gut, 2010; 59: 1728-1729; author reply 1729-1730","DOI":"10.1136\/gut.2009.194100"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jain MK and Ridker PM: Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov, 2005; 4: 977-987","DOI":"10.1038\/nrd1901"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chen H, Cheng L, Yang S, Liu X, Liu Y, Tang J, Li X, He Q and Zhao S: Molecular characterization, induced expression, and transcriptional regulation of porcine S100A12 gene. Mol Immunol, 2010; 47: 1601-1607","DOI":"10.1016\/j.molimm.2010.01.024"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Li X, Tang J, Xu J, Zhu M, Cao J, Liu Y, Yu M and Zhao S: The inflammation-related gene S100A12 is positively regulated by C\/EBPbeta and AP-1 in pigs. Int J Mol Sci, 2014; 15: 13802-13816","DOI":"10.3390\/ijms150813802"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Matsumoto M, Einhaus D, Gold ES and Aderem A: Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol, 2004; 172: 7377-7384","DOI":"10.4049\/jimmunol.172.12.7377"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Mouawad CA, Mrad MF, Al-Hariri M, Soussi H, Hamade E, Alam J and Habib A: Role of nitric oxide and CCAAT\/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages. PLoS One, 2013; 8: e64092","DOI":"10.1371\/journal.pone.0064092"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Pirro M, Simental-Mendia LE, Bianconi V, Watts GF, Banach M and Sahebkar A: Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET\/CT: A Systematic Review and Meta-Analysis of Interventional Studies. J Clin Med, 2019; 8:","DOI":"10.3390\/jcm8010118"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T and Murohara T: Comparison of atorvastatin 5 and 20 mg\/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography\/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Clin Ther, 2010; 32: 2337-2347","DOI":"10.1016\/j.clinthera.2010.12.001"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Yogo M, Sasaki M, Ayaori M, Kihara T, Sato H, Takiguchi S, Uto-Kondo H, Yakushiji E, Nakaya K, Komatsu T, Momiyama Y, Nagata M, Mochio S, Iguchi Y and Ikewaki K: Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study. Atherosclerosis, 2014; 232: 31-39","DOI":"10.1016\/j.atherosclerosis.2013.10.007"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Masoura C, Pitsavos C, Aznaouridis K, Skoumas I, Vlachopoulos C and Stefanadis C: Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis, 2011; 214: 129-138","DOI":"10.1016\/j.atherosclerosis.2010.10.008"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Antonopoulos AS, Margaritis M, Shirodaria C and Antoniades C: Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation. Thromb Haemost, 2012; 108: 840-848","DOI":"10.1160\/TH12-05-0337"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/5\/29_61630\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:28:48Z","timestamp":1715232528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/5\/29_61630\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.61630","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,1]]},"article-number":"61630"}}